Avsnitt
-
As more people either delay or seek alternative routes to starting families, fertility care has become a vital part of modern healthcare. In this episode of Health Care in Action, Boston IVF CEO David Stern takes us inside the cutting-edge world of in-vitro fertilization (IVF). Learn how advancements in embryo culture, genetic testing, and AI are improving success rates and creating personalized treatment plans. David also shares how Boston IVF’s innovative approach to patient care is making fertility treatment more accessible and breaking down common barriers like cost, travel, and stigma.
Key takeaways from this episode:
How advancements in embryo culture and genetic testing have dramatically improved success rates while reducing risks like multiple birthsHow Boston IVF's hub-and-spoke model makes treatment more accessible and convenient, addressing common barriers like cost and travel timeHow new technologies like AI and customized patient management systems are reshaping the IVF landscapeWhy addressing the stigma of infertility is important to bridging the communication gap between patients and practitionersTo learn more about THL’s cross-sector strategy to uncover opportunities in emerging technologies, visit THL.com/automation
-
Welcome to Healthcare in Action! A podcast that explores how innovations and business models are transforming U.S. healthcare.
Hosts Josh Nelson, Head of Healthcare at THL Partners, and Jon Lange will be exploring the cutting-edge developments redefining the healthcare landscape. From AI and automation revolutionizing patient care to improved data quality and groundbreaking partnerships, this podcast brings you conversations with the people driving these changes.
To learn more about THL’s cross-sector strategy to uncover opportunities in emerging technologies, visit thl.com/verticals/healthcare.
-
Saknas det avsnitt?
